drugset / Trial / NCT02009189

Taurolidine Lock in Long Term Parenteral Nutrition

NCT02009189

Phase 4 Completed 30 enrolled Stanley Dudrick's Memorial Hospital
RandomizedFactorialOpen-labelPrevention

Summary

Taurolidine alone or in combination with citrate have been proposed for locking the catheter to reduce the number of catheter infections. As there is not enough evidence to give recommendations in this regard, the study tested the hipothesis that taurolidine improves the outcome of long term paretneral nutrition.

Timeline

Start
2012-11
Primary completion
2013-11
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator taurolidine Small molecule 1.35 %
Comparator taurolidine Small molecule 2 %

Indications

No indication recorded.